Cabergoline en es it fr

Cabergoline Brand names, Cabergoline Analogs

Cabergoline Brand Names Mixture

  • No information avaliable

Cabergoline Chemical_Formula


Cabergoline RX_link

Cabergoline fda sheet

Cabergoline msds (material safety sheet)

Cabergoline Synthesis Reference

No information avaliable

Cabergoline Molecular Weight

451.604 g/mol

Cabergoline Melting Point

102 - 104 oC

Cabergoline H2O Solubility


Cabergoline State


Cabergoline LogP


Cabergoline Dosage Forms

Tablets for oral administration (0.5 mg)

Cabergoline Indication

For the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.

Cabergoline Pharmacology

Cabergoline is a dopamine receptor agonist and uncategorized drug which suppresses the production of prolactin in pituitary gland. It is an ergot-derivative. It has at times been used as an adjunct to SSRI antidepressants as there is some evidence that it counteracts certain side effects of those drugs such as reduced libido and anorgasmia. It also has been suggested online that it has a possible recreational use in reducing or eliminating the male refractory period.

Cabergoline Absorption

First-pass effect is seen, however the absolute bioavailability is unknown.

Cabergoline side effects and Toxicity

Overdosage might be expected to produce nasal congestion, syncope, or hallucinations.

Cabergoline Patient Information

Cabergoline Organisms Affected

Humans and other mammals